They authorize the human trial of the therapy against pancreatic cancer designed in Euskadi

Drug agencies in Europe and the United States have given their approval to the human trial of what could become the world's first therapy against pancreatic cancer, a drug designed by the Basque company Oncomatryx.

They authorize the human trial of the therapy against pancreatic cancer designed in Euskadi

Drug agencies in Europe and the United States have given their approval to the human trial of what could become the world's first therapy against pancreatic cancer, a drug designed by the Basque company Oncomatryx. The drug from the firm based in Derio, which has obtained "excellent results" in models to


7

You need to login to comment.

Please register or login.

RELATED NEWS